Annual Operating Expenses
$527.23 M
+$78.02 M+17.37%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual total operating expenses is $527.23 million, with the most recent change of +$78.02 million (+17.37%) on December 31, 2023.
- During the last 3 years, DNLI annual operating expenses has risen by +$254.29 million (+93.17%).
- DNLI annual operating expenses is now at all-time high.
Performance
DNLI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$123.19 M
+$6.59 M+5.66%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly total operating expenses is $123.19 million, with the most recent change of +$6.59 million (+5.66%) on September 30, 2024.
- Over the past year, DNLI quarterly operating expenses has increased by +$6.59 million (+5.66%).
- DNLI quarterly operating expenses is now -21.01% below its all-time high of $155.96 million, reached on March 31, 2023.
Performance
DNLI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DNLI Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.4% | +5.7% |
| 3 y3 years | +93.2% | +6.5% |
| 5 y5 years | +200.4% | +6.5% |
DNLI Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.1% | -21.0% | +37.4% |
| 5 y | 5-year | at high | +119.8% | -21.0% | +97.3% |
| alltime | all time | at high | +3061.0% | -21.0% | +522.9% |
Denali Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $123.19 M(+5.7%) |
| Jun 2024 | - | $116.59 M(-11.8%) |
| Mar 2024 | - | $132.25 M(-0.2%) |
| Dec 2023 | $527.23 M(+17.4%) | $132.57 M(+15.2%) |
| Sep 2023 | - | $115.06 M(-6.9%) |
| Jun 2023 | - | $123.64 M(-20.7%) |
| Mar 2023 | - | $155.96 M(+34.9%) |
| Dec 2022 | $449.21 M(+30.4%) | $115.63 M(+4.1%) |
| Sep 2022 | - | $111.05 M(-2.5%) |
| Jun 2022 | - | $113.90 M(+4.8%) |
| Mar 2022 | - | $108.64 M(+21.2%) |
| Dec 2021 | $344.41 M(+26.2%) | $89.64 M(-1.4%) |
| Sep 2021 | - | $90.88 M(+7.2%) |
| Jun 2021 | - | $84.76 M(+7.1%) |
| Mar 2021 | - | $79.14 M(+8.8%) |
| Dec 2020 | $272.94 M | $72.74 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $69.51 M(+3.6%) |
| Jun 2020 | - | $67.12 M(+5.6%) |
| Mar 2020 | - | $63.57 M(+1.8%) |
| Dec 2019 | $239.86 M(+36.6%) | $62.43 M(-2.1%) |
| Sep 2019 | - | $63.76 M(-4.8%) |
| Jun 2019 | - | $66.96 M(+43.3%) |
| Mar 2019 | - | $46.71 M(-8.3%) |
| Dec 2018 | $175.53 M(+94.7%) | $50.95 M(+30.1%) |
| Sep 2018 | - | $39.16 M(-33.7%) |
| Jun 2018 | - | $59.03 M(+123.7%) |
| Mar 2018 | - | $26.39 M(+12.1%) |
| Dec 2017 | $90.14 M(+3.1%) | $23.54 M(+5.6%) |
| Sep 2017 | - | $22.29 M(-1.2%) |
| Jun 2017 | - | $22.57 M(+3.8%) |
| Mar 2017 | - | $21.74 M(+10.0%) |
| Dec 2016 | $87.43 M(+424.2%) | $19.78 M |
| Dec 2015 | $16.68 M | - |
FAQ
- What is Denali Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Denali Therapeutics?
- What is Denali Therapeutics annual operating expenses year-on-year change?
- What is Denali Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Denali Therapeutics?
- What is Denali Therapeutics quarterly operating expenses year-on-year change?
What is Denali Therapeutics annual total operating expenses?
The current annual operating expenses of DNLI is $527.23 M
What is the all time high annual operating expenses for Denali Therapeutics?
Denali Therapeutics all-time high annual total operating expenses is $527.23 M
What is Denali Therapeutics annual operating expenses year-on-year change?
Over the past year, DNLI annual total operating expenses has changed by +$78.02 M (+17.37%)
What is Denali Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of DNLI is $123.19 M
What is the all time high quarterly operating expenses for Denali Therapeutics?
Denali Therapeutics all-time high quarterly total operating expenses is $155.96 M
What is Denali Therapeutics quarterly operating expenses year-on-year change?
Over the past year, DNLI quarterly total operating expenses has changed by +$6.59 M (+5.66%)